Bibliographic Details
| Title: |
Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States. |
| Authors: |
Farber, Harrison W., Germack, Hayley D., Croteau, Nicole S., Simeone, Jason C., Tang, Fei, Paoli, Carly J., Doad, Gurinderpal, Panjabi, Sumeet, De Marco, Teresa |
| Source: |
Pulmonary Circulation; Apr2024, Vol. 14 Issue 2, p1-5, 5p |
| Subject Terms: |
PULMONARY arterial hypertension, TERMINATION of treatment, PULMONARY hypertension |
| Geographic Terms: |
UNITED States |
| Abstract: |
Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pulmonary Circulation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
